In late-stage Alzheimer's disease, the brain has undergone widespread degeneration that leads to a global loss of function. At this final stage you commonly see behavior changes and disorientation as memory and awareness become severely impaired. Speech becomes very limited or may be lost, swallowing can become difficult (dysphagia), and mobility declines, resulting in impaired walking. This combination of profound cognitive decline, language loss, swallowing problems, and motor impairment is characteristic of the most advanced phase of Alzheimer's. Other dementias tend to show different patterns. Vascular dementia often progresses in a stepwise fashion with more pronounced focal problems from strokes. Lewy body dementia may present earlier with fluctuations in attention, visual hallucinations, and parkinsonian motor symptoms. Frontotemporal dementia typically starts with noticeable changes in personality or language abilities rather than the broad, late-stage decline described here.

Hoover sign is used to distinguish functional (non-organic) leg weakness from true neurological weakness. When you ask the patient to flex the hip of the leg being tested, you simultaneously feel the heel of the opposite leg. In a person with genuine weakness, there is little to no pressure from the contralateral leg as the tested leg is moved. If the opposite leg does press downward into the bed or you feel deliberate pushing while the patient attempts to move the weak leg, it shows the patient is capable of generating force, suggesting the weakness is functional rather than organic. This is why Hoover sign is the best indicator for functional leg weakness.

Grouping personality disorders into clusters helps clinicians recognize shared patterns of behavior and traits. The cluster described as dramatic, emotional, and erratic includes Narcissistic, Histrionic, Borderline, and Antisocial personality disorders. Each of these disorders features prominent interpersonal challenges and intense or unstable patterns of functioning: Narcissistic with grandiosity and need for admiration; Histrionic with excessive emotionality and a strong desire to be noticed; Borderline with rapidly changing emotions and unstable relationships; and Antisocial with disregard for rules and the rights of others. Together, they form the dramatic/erratic cluster due to these common social and affective dynamics. The other clusters describe different patterns. One cluster is the odd or eccentric group, including paranoid, schizoid, and schizotypal traits, which don’t align with the dramatic emphasis. Another cluster is anxious or fearful, covering avoidant, SAMPLEdependent, and obsessive-compulsive types, which also differ in their core presentation. Hence, the four disorders listed belong to the dramatic, emotional, and erratic cluster.

The key idea is safety in pharmacologic treatment for bulimia nervosa. Bupropion stands out because it lowers the seizure threshold, and in bulimia nervosa patients there are often electrolyte disturbances from purging (like low potassium or chloride) that further raise seizure risk. Because of this heightened risk, bupropion is avoided in bulimia. In contrast, fluoxetine and sertraline are SSRIs with evidence supporting their use for bulimia and they don’t have the same seizure risk profile in this context. Vyvanse is a stimulant not standardly used to treat bulimia nervosa, so it isn’t the medication chosen for this scenario.

Norepinephrine helps regulate mood, arousal, and attention, so it ties together depression, ADHD, and anxiety. In depression, lower norepinephrine can contribute to low energy and mood, and treatments that boost its activity (like norepinephrine reuptake inhibitors) can help lift mood and energy. In ADHD, norepinephrine supports focus and executive control; many ADHD medications increase norepinephrine in the prefrontal cortex to improve attention and impulse control. In anxiety, heightened adrenergic activity drives arousal and worry, so dysregulated norepinephrine can worsen anxious symptoms. While other neurotransmitters like dopamine, GABA, and acetylcholine play roles in related functions, norepinephrine uniquely intersects mood, attention, and arousal in this trio, making it the best answer.